Connect with us

Health

Immune tolerance in hemophilia can be modulated by B cell activating factor – News-Medical.Net

A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people…

Published

on

Article feature image
ADVERTISEMENT

A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A.
Hemophilia is the most common severe inherited bleeding disorder in men. The disease affects 1 in 10,000 males worldwide and results from deficiency of blood clotting factor VIII (FVIII).
Both children and adults with hemophilia A (80 percent of all hemophilia) receive treatment that involves infusing FVIII protein…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Cooking a curry? Your rice could be hiding micro-plastics, warn scientists – The New Daily
Article feature image
A psychedelic drug boom in mental health treatment comes closer to reality – CNBC